… The purpose of this study is to evaluate the effect blocking neurokinin 1 receptor (NK1R)
signaling has on the CD8 T cell response to corneal herpes simplex 1 (HSV-1) infection, using …

… Care in Cancer (MASCC) for chemotherapy-induced nausea and vomiting (CINV), a combination
of a NK1 receptor … of emesis for patients treated with carboplatin-based chemotherapy. …

… belongs to the group of neurokinins, the COVID-19 infection, and air … These effects are
independent of the NK 1 receptor. … , for the therapy of severe COVID courses. Mehboob proposed …

… Coronavirus disease 2019 (COVID-19). For this reason, many researchers have tried to
implement therapies to mitigate the cytokine storm in the treatment of COVID-19 … in COVID-19 …

… used 19 F-NMR observation of aprepitant, which is an approved drug that targets NK1R for
the treatment … health officials with early warnings for new COVID-19 outbreaks, but to date, no …

… the proinflammatory and mitogenic neurokinin-1 receptor (NK-1R)… truncated (tr-NK-1R) and
full-length (fl-NK-1R) receptors by … NK-1R may play a functional role in the disease; treatment …

… Furthermore, we propose a new therapeutic approach for the prevention and treatment of
COVID-19 disease: the combination of an NK-1R inhibitor and the glucocorticoid …

… treatments (eg 5-HT 3 and NK 1 receptor antagonists). Further studies of mechanisms are
needed and in addition to in vitro studies of EEC cell lines these may include studies in the …

… COVID-19 treatment options which are currently under investigation. For each drug deemed
to be potentially effective on COVID-19 … -2 or may affect COVID-19 pathogenesis, then we …

… analgesic activity most likely mediated through the blockade of neurokinin-1 receptor (NK1R),
the substance P (SP)-preferring receptor. The ability of vapreotide to interfere with other …